CD4+ count-guided interruption of antiretroviral treatment.

By W. El-Sadr, J. Lundgren, J. Neaton, F. Gordin, D. Abrams, R. Arduino, A. Babiker, W. Burman, N. Clumeck, C. Cohen and 14 more. New England Journal of Medicine, 2006

1,879 citations recorded by the source corpus.

Subfields: Emergency Medicine, Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/3fa0de0cc95630bf10bfe655ce8f332e497117c9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Guaraldi
2. G. Orlando
3. S. Zona
4. M. Menozzi
5. F. Carli
6. E. Garlassi
7. A. Berti
8. S. Walmsley

Citations in the corpus

• Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. (2008, background): “Uncontrolled viral replication is associated with the development of non-AIDS diseases, and renal disease is more prevalent in untreated HIV infection.(27,35,36)”
• Premature age-related comorbidities among HIV-infected persons compared with the general population. (2011, result): “NICMs that are associated with lower nadir CD4 cell count and the simultaneously apparent increased risk of NICM secondary to cumulative exposure to ART [32, 34] has been at least partially resolved by findings from the SMART (Strategies for the Management of Antiretroviral Therapy) study that have ”
• Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients (2008, neutral): “Outcomes assessed In SMART, cardiovascular events were collected and adjudicated by an Endpoint Review Committee using prespecified criteria for each event [4,8].”